E-LIB Suche - Ergebnisse für: Venugopal, Sangeetha

1

Cricket Player Prediction of Role in a Team Using ML Techni..:

, In: 2024 International Conference on E-mobility, Power Control and Smart Systems (ICEMPS),

Trinadh, Myreddy Kumar Durga ; Sangeetha, S. Tresa ; K, Deepa. - p. 1-5 , 2024

Link: https://doi.org/10.1109/..

2

Venetoclax and hypomethylating agents in octogenarians and ..:

Madarang, Ellen ; Lykon, Jillian ; Zhao, Wei...
Blood Neoplasia. 1 (2024) 2 - p. 100016 , 2024

Link: https://doi.org/10.1016/..

3

Oral streptococciS. anginosusandS. mitisinduce distinct mor..:

Senthil Kumar, Sangeetha ; Gunda, Venugopal ; Reinartz, Dakota M....
Infection and Immunity. 92 (2024) 3 - p. , 2024

Link: https://doi.org/10.1128/..

4

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology. 11 (2024) 3 - p. e186-e195 , 2024

Link: https://doi.org/10.1016/..

5

A Comparative Analysis of Eye Movement and Gaze Tracking Al..:

, In: Human-Centric Smart Computing; Smart Innovation, Systems and Technologies,

Advith, N. N. ; Sangeetha, J. ; Dhanunjaya Reddy, B... - p. 285-295 , 2024

Link: https://doi.org/10.1007/..

6

Data-Driven Models for Water Potability: A Machine Learning..:

, In: 2024 Third International Conference on Intelligent Techniques in Control, Optimization and Signal Processing (INCOS),

Mishra, Nisha ; Sangeetha, S. V. Tresa ; K, Deepa. - p. 1-6 , 2024

Link: https://doi.org/10.1109/..

7

Targeted therapy with the mutant IDH2 inhibitor enasidenib ..:

DiNardo, Courtney D. ; Venugopal, Sangeetha ; Lachowiez, Curtis...
Blood Advances. 7 (2023) 11 - p. 2378-2387 , 2023

Link: https://doi.org/10.1182/..

8

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
HemaSphere. 7 (2023) S3 - p. e18588ff , 2023

Link: https://doi.org/10.1097/..

9

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN ..:

Bazinet, Alexandre ; Prasad Desikan, Sai ; LI, Ziyi...
HemaSphere. 7 (2023) S3 - p. e554617b , 2023

Link: https://doi.org/10.1097/..

10

Olutasidenib: from bench to bedside:

Venugopal, Sangeetha ; Watts, Justin
Blood Advances. 7 (2023) 16 - p. 4358-4365 , 2023

Link: https://doi.org/10.1182/..

11

List of contributors:

, In: Marine Antioxidants,

Ali, Aaliya ; Anandan, R. ; Anas, K.K.... - p. xv-xix , 2023

Link: https://doi.org/10.1016/..

12

Clinical outcomes associated with NPM1 mutations in patient..:

Issa, Ghayas C. ; Bidikian, Aram ; Venugopal, Sangeetha...
Blood Advances. 7 (2023) 6 - p. 933-942 , 2023

Link: https://doi.org/10.1182/..

13

Trying to outRun‐DIC in KMT2Ar AML: It's tricky:

Venugopal, Sangeetha ; Taylor, Justin
Cancer. 129 (2023) 12 - p. 1797-1799 , 2023

Link: https://doi.org/10.1002/..

14

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428441/. , 2023

Link: http://www.ncbi.nlm.nih...

15

The future paradigm of HMA + VEN or targeted inhibitor appr..:

Venugopal, Sangeetha ; Watts, Justin
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727059/. , 2023

Link: http://www.ncbi.nlm.nih...